Neurelis
CA - San DiegoBiotechnology
Focus: Neurelis is a micro-cap biotech focused on licensing, developing, and commercializing product candidates in neurology and psychiatry. The company operates as a single-product entity with minimal scale (1-50 employees) based in San Diego.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Employees
1-50
Open Jobs
4
Should You Work at Neurelis?
AI assessmentNeurelis is a high-risk/high-reward micro-cap suitable only for professionals seeking early-stage exposure and outsized impact in exchange for significant financial and career instability.
Why Work Here
- VALTOCO (diazepam nasal spray) is at peak lifecycle with $17M Part D spending and patent protection through 2032, providing revenue stability — critical for a micro-cap
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$17M Part DStable
Peak6.3yr
Help build intelligence for Neurelis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.